American International Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,388
Closed -$52K 4191
2016
Q1
$52K Sell
2,388
-186
-7% -$4.25K ﹤0.01% 3868
2015
Q4
$81K Buy
2,574
+1,323
+106% +$40.5K ﹤0.01% 3638
2015
Q3
$35K Buy
1,251
+690
+123% +$24.1K ﹤0.01% 4078
2015
Q2
$19.9K Buy
561
+411
+274% +$13.4K ﹤0.01% 4380
2015
Q1
$4.48K Buy
+150
New +$4.22K ﹤0.01% 4725

Other funds holding SBIO

American International Group's SBIO Position: Q2 2016 in Review

American International Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2016, closing a stake of 2,388 shares — an estimated $52K sold.

American International Group first reported a position in SBIO in Q1 2015 and held it in 5 quarters. The position peaked at $81K in Q4 2015. 27 funds tracked by Wall St. Rank hold SBIO as of Q2 2016.

  • American International Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 2,388 ALPS Medical Breakthroughs ETF shares in Q2 2016, an estimated $52K.
  • American International Group first reported a position in ALPS Medical Breakthroughs ETF in Q1 2015 and held it in 5 quarters.
  • American International Group's ALPS Medical Breakthroughs ETF position peaked at $81K in Q4 2015.
  • 27 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.